Lv1
56 积分 2025-12-29 加入
Standardization of Procedures for the Preparation of 177Lu- and 90Y-labeled DOTA-Rituximab Based on the Freeze-dried Kit Formulation
23天前
已完结
CD33‐Targeted Therapies: Beating the Disease or Beaten to Death?
1个月前
已完结
SIGLEC-3 (CD33) serves as an effective target in tumor progression
1个月前
已关闭
Antibody-drug Conjugate Biomarker Expression in Gestational Trophoblastic Disease: Folate Receptor Alpha, Nectin-4, Trop-2, and Tissue Factor. Int J Gynecol Pathol
1个月前
已关闭
Current Status and Perspectives of Novel Radiopharmaceuticals with Heterologous Dual-targeted Functions: 2013-2023
1个月前
已完结
High-plasticity oncofetal cell states in early pre-metastatic colorectal cancer
2个月前
已完结
A Novel CD147-Targeting Nanobody for Immuno-PET Imaging of Liver Cancer
3个月前
已完结
Exploring the 89 Zr/ 177 Lu Theranostic Pairing with an Extracellular Matrix Targeted Radiopharmaceutical Against Triple Negative Breast Cancer
7个月前
已完结
Novel Mitochondria-Targeted NIR Cyanine Cy750M-C1 Nanoparticles for Chemotherapy against Triple-Negative Breast Cancer
9个月前
已完结
皖公网安备34019202002308
